Posted on 05/05/08
After a week of setbacks, Merck fights 'credibility deficit'
TRENTON, N.J. -- The roller coaster ride for Merck & Co. Inc. shareholders and employees is on another speedy downhill run.In barely a week, Merck has suffered a stunning streak of setbacks, including U.S. federal regulators rejecting two experimental drugs and publicly demanding the drug maker clean up significant problems at its main vaccine plant.
The full text of this article has 691 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
